In vitro Ingavirin® Efficacy Against Adenoviral Infection Pathogen
The experimental investigation of the Ingavirin® antiviral effect showed that in concentrations of 200 and 100 mcg/ml it totally protected the cells from the cytopathic action of the virus, when added before the inoculation of the HeLa cell culture. After a tenfold decrease of the infective dose (up...
Saved in:
| Main Authors: | S. YA. Loginova, S. V. Borisevich, V. A. Maksimov, V. P. Bondarev, V. E. Nebolsin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC "Publishing House OKI"
2020-05-01
|
| Series: | Антибиотики и Химиотерапия |
| Subjects: | |
| Online Access: | https://www.antibiotics-chemotherapy.ru/jour/article/view/247 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In vitro Investigation of Ingavirin® Efficacy Against Influenza B Virus
by: S. YA. Loginova, et al.
Published: (2020-05-01) -
Investigation of in vitro Activity of Ingavirin® Against Influenza Virus A (H3N2)
by: S. YA. Loginova, et al.
Published: (2020-05-01) -
Experimental Study of Ingavirin® Antiviral Activity Against Human Adenovirus
by: V. V. Zarubaev, et al.
Published: (2020-05-01) -
Prophylactic and Therapeutic Efficacies of Ingavirin®, a Novel Russian Chemotherapeutic, with Respect to Influenza Pathogen A (H5N1)
by: S. YA. Loginova, et al.
Published: (2020-05-01) -
In vitro Efficacy of Ingavirin Against the Mexican Pandemic Subtype H1N1 of Influenza A Virus, Strains A/California/04/2009 and A/California/07/2009
by: S. YA. Loginova, et al.
Published: (2020-05-01)